Literature DB >> 21712025

FcεRI, but not FcγR, signals induce prostaglandin D2 and E2 production from basophils.

Tsukasa Ugajin1, Takahiro Satoh, Toru Kanamori, Kosuke Aritake, Yoshihiro Urade, Hiroo Yokozeki.   

Abstract

Prostaglandin (PG) D2 and PGE2 are arachidonic acid metabolites that are generated though an isomerization reaction catalyzed by PG synthases. PGs have been implicated in immunologic reactions in addition to a wide range of physiological functions. It has long been thought that basophils, in contrast to mast cells, do not synthesize PGs, although they do release leukotrienes and platelet-activating factor. Here, we show that basophils function as a source of PGD2 and PGE2. In vitro-cultured basophils from mouse bone marrow produced both PGD2 and PGE2 in response to IgE + antigen (Ag), but not to IgG + Ag. Release of PGs was almost completely abrogated in cultured basophils from FcRγ-chain(-/-) mice, indicating the involvement of FcεRI. Basophils freshly isolated from bone marrow cells (primary basophils) were also capable of secreting PGD2 and PGE2. Although the amount of PGD2 released from primary basophils was lower than that from mast cells, the capability of primary basophils to generate PGE2 was more potent than that of mast cells. Transcripts and proteins for both hematopoietic-type PGD synthase and PGE synthase were detected in basophils. In addition, human basophils, like mouse basophils, also produced PGD2 through IgE-mediated stimulation. Thus, basophils could be an important source of PGD2/PGE2 and may contribute to allergic inflammation and immune responses.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712025      PMCID: PMC3157207          DOI: 10.1016/j.ajpath.2011.04.023

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.

Authors:  Kaori Mukai; Kunie Matsuoka; Choji Taya; Hidenori Suzuki; Hiroo Yokozeki; Kiyoshi Nishioka; Katsuiku Hirokawa; Maki Etori; Makoto Yamashita; Toshiyuki Kubota; Yoshiyuki Minegishi; Hiromichi Yonekawa; Hajime Karasuyama
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  Identification of basophils by a mAb directed against pro-major basic protein 1.

Authors:  Douglas A Plager; Ellen A Weiss; Gail M Kephart; Robert M Mocharla; Ryoji Matsumoto; James L Checkel; Lawrence B Schwartz; Gerald J Gleich; Kristin M Leiferman
Journal:  J Allergy Clin Immunol       Date:  2006-01-27       Impact factor: 10.793

Review 3.  Prostanoid receptors: structures, properties, and functions.

Authors:  S Narumiya; Y Sugimoto; F Ushikubi
Journal:  Physiol Rev       Date:  1999-10       Impact factor: 37.312

4.  Mast cells contain spleen-type prostaglandin D synthetase.

Authors:  Y Urade; M Ujihara; Y Horiguchi; M Igarashi; A Nagata; K Ikai; O Hayaishi
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

5.  Mediator release after endobronchial antigen challenge in patients with respiratory allergy.

Authors:  A Miadonna; A Tedeschi; C Brasca; G Folco; A Sala; R C Murphy
Journal:  J Allergy Clin Immunol       Date:  1990-05       Impact factor: 10.793

6.  A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking.

Authors:  K L Nguyen; S Gillis; D W MacGlashan
Journal:  J Allergy Clin Immunol       Date:  1990-06       Impact factor: 10.793

Review 7.  Prostaglandin D2 and sleep regulation.

Authors:  Y Urade; O Hayaishi
Journal:  Biochim Biophys Acta       Date:  1999-01-04

8.  Basophil mediator release in atopic dermatitis.

Authors:  H A Bull; P F Courtney; C B Bunker; M H Rustin; F L Pearce; P M Dowd
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

9.  Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links.

Authors:  D W MacGlashan; S P Peters; J Warner; L M Lichtenstein
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

10.  The pharmacologic control of mediator release from human basophils and mast cells.

Authors:  S P Peters; R M Naclerio; R P Schleimer; D W MacGlashan; U Pipkorn; L M Lichtenstein
Journal:  Respiration       Date:  1986       Impact factor: 3.580

View more
  17 in total

1.  Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation.

Authors:  Tatiana Luna-Gomes; Kelly G Magalhães; Fabio P Mesquita-Santos; Ilka Bakker-Abreu; Rafaela F Samico; Raphael Molinaro; Andrea S Calheiros; Bruno L Diaz; Patrícia T Bozza; Peter F Weller; Christianne Bandeira-Melo
Journal:  J Immunol       Date:  2011-11-18       Impact factor: 5.422

Review 2.  The role of basophils as innate immune regulatory cells in allergy and immunotherapy.

Authors:  Salvatore Chirumbolo; Geir Bjørklund; Andrea Sboarina; Antonio Vella
Journal:  Hum Vaccin Immunother       Date:  2018-01-18       Impact factor: 3.452

Review 3.  Basophils in antihelminth immunity.

Authors:  Jianya Peng; Mark C Siracusa
Journal:  Semin Immunol       Date:  2021-11-21       Impact factor: 11.130

4.  Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.

Authors:  Naoko Kataoka; Takahiro Satoh; Aiko Hirai; Kazumi Saeki; Hiroo Yokozeki
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

5.  IgE cross-linking critically impairs human monocyte function by blocking phagocytosis.

Authors:  David M Pyle; Victoria S Yang; Rebecca S Gruchalla; J David Farrar; Michelle A Gill
Journal:  J Allergy Clin Immunol       Date:  2013-02       Impact factor: 10.793

6.  Murine cutaneous responses to the rocky mountain spotted fever vector, Dermacentor andersoni, feeding.

Authors:  Dar M Heinze; J Russ Carmical; Judith F Aronson; Franscisco Alarcon-Chaidez; Stephen Wikel; Saravanan Thangamani
Journal:  Front Microbiol       Date:  2014-05-07       Impact factor: 5.640

7.  Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.

Authors:  Dirk Schäfer; Peter Dreßen; Stefan Brettner; Norbert-Folke Rath; Gerhard J Molderings; Katrin Jensen; Christina Ziemann
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

8.  Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.

Authors:  Kathleen M Buchheit; Erin Lewis; Deborah Gakpo; Jonathan Hacker; Aaqib Sohail; Faith Taliaferro; Evans Berreondo Giron; Chelsea Asare; Marko Vukovic; Jillian C Bensko; Daniel F Dwyer; Alex K Shalek; Jose Ordovas-Montanes; Tanya M Laidlaw
Journal:  J Allergy Clin Immunol       Date:  2021-06-16       Impact factor: 14.290

9.  9α,11β-PGF2, a Prostaglandin D2 Metabolite, as a Marker of Mast Cell Activation in Bee Venom-Allergic Patients.

Authors:  Marita Nittner-Marszalska; Ewa Cichocka-Jarosz; Marek Sanak; Magdalena Wujczyk; Anna Dor-Wojnarowska; Grzegorz Lis; Jerzy Liebhart
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-03-13       Impact factor: 4.291

10.  IgE-mediated 15-hydroxyeicosatetraenoic acid (15-HETE) generation by peripheral blood leukocytes: its association with basophil activation.

Authors:  Anna Michalak; Anna Lewandowska-Polak; Sylwia Moskwa; Marek L Kowalski; Janina Ł Grzegorczyk
Journal:  Postepy Dermatol Alergol       Date:  2015-08-12       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.